Social
SOCIAL
Our commitment to society and our employees
At the heart of our activities lies the health of both humans and animals. R&D+i is one of our main tools in the search for health and nutritional solutions. We ensure high quality and safety of our products throughout the entire process, from supply chain control to after-sales service that allows us to manage possible adverse reactions and special situations.
Our employees embody the Group’s values and are the driving force behind achieving our purpose. We are deeply committed to fostering a safe, healthy, and tolerant workplace, where talent is provided with the tools needed for development.
Health and safety in society
Our performance in 2025
- We promote training and information programs for healthcare professionals, focused on the patient and improving the quality of healthcare.
- We incorporate the patient’s perspective into the design and development of our activities to meet their real needs.
- We are present in new therapeutic areas: ophthalmology and dermatology.
- Investment and spending in R&D for the discovery of new drugs and pharmaceutical and clinical development has exceeded €30.2 million in 2025.
What are we working to improve?
- Collaborating with patient associations to understand their needs firsthand and promote educational/informational programs that contribute to improving knowledge about diseases.
- Implementing measures that facilitate access to information on medicines, medical devices, cosmetics, and/or food.
- Researching and developing innovative medicines, as well as optimizing formulations that facilitate administration, promote adherence, and generate a positive impact on patients’ quality of life.
Occupational health and safety
Our performance in 2025
- 100% of our own staff are covered by our health and safety management system.
- The Sifi plant in Italy has renewed its ISO 45001 certification.
- We have updated the Group’s Health and Safety Policy.
What are we working to improve?
- Continuing with the regular meetings of the safety and health committees, commissions and improvement groups, for the identification of needs in this area.
- As the Group’s employee numbers and facilities grow, we’re intensifying our efforts to adhere to our three-pillar preventive culture: promoting health, preventing occupational risks, and providing health and prevention training.
Equality
Our performance in 2025
- 55% women in the Group’s workforce (vs 54% in 2024).
- The pay gap is 3.6% (an improvement from 4% in 2024).
- 94% of employees have permanent contracts.
- We formalized the Group’s “Diversity, Equity and Inclusion Policy”.
- We developed and disseminated the ‘Guide to inclusive corporate communication’.
What are we working to improve?
- Defining the onboarding protocol in order to welcome and share our purpose with new employees.
- Improving the gender pay gap and the proportion of women in leadership positions.
- We continue to ensure compliance with the measures defined in the Equality Plans of Faes Farma S.A, Tecnovit and Ingaso.
Our contribution to the community
Our performance in 2025
- We are making progress in the ‘Jovenes en Faes Farma’ scholarship program, formalizing agreements and collaborations with university and educational centers.
- Animal Nutrition and Health plants promote employment in an environment affected by rural depopulation.
- We donated more than 145,000 euros to entities that contribute mainly to SDG 2 Hunger and Food Security and SDG 3 Health.
What are we working to improve?
- We reflect on priority social actions in line with our values in order to define Group’ social action policy.
- We continue to collaborate with universities and educational institutions, promoting the development of local employment.
- We set up the ‘Young people at Faes Farma’ scholarship programme’.
Supply chain
Our performance in 2025
- We have updated the Third Party Code of Ethics and Conduct and the process for acceptance of our commitment by key suppliers.
What are we working to improve?
- Implementing a supplier selection and management system that integrates their ESG performance.
- Defining a logistics decarbonization plan.
- Developing a risk assessment program and ESG performance evaluation of key suppliers.